期刊文献+

从视神经病变到脊髓损伤间隔37年的视神经脊髓炎一例并文献复习 被引量:2

A case report of neuromyelitis optica with 37 years' interval between optic neuropathy and spinal cord lesion and literature review
原文传递
导出
摘要 目的 提高对从视神经病变到脊髓损伤间隔长的视神经脊髓炎(NMO)的认识,以减少误诊。方法 对1例从视神经病变到脊髓损伤间隔37年的NMO患者行血、脑脊液化验及脊髓、头颅MRI等检查,分析临床资料、随访并文献复习。结果 患者脑脊液碱性髓鞘蛋白及IgG合成率均偏高,寡克隆区带阳性,视觉诱发电位异常,脊髓MRI可见T1-7。髓内长T2异常信号,诊断明确后经过糖皮质类同醇和丙种球蛋白治疗后患者症状明显好转。目前随访病情稳定。结论 从视神经病变到脊髓损伤可以间隔相当长的时间。当患者出现视神经炎时,要注意亚临床脊髓及头颅病变的筛查,注意是否有转变成为NMO或多发性硬化的可能性。 Objective To improve the reeognization of long term interval between optic neuropathy and spinal cord injury of neuromyelitis optica. Methods One 51-year old male patient with 37 years' interval between optic neuropathy and spinal cord injury of neuromyelitis optiea underwent the examination of plasma and cerebrospinal fluid and head and spinal MRI examinations, who was also followed up. His clinical data were analyzed and related literature was reviewed. Results The myelin basic protein and lgG index in his cerebrospinal fluid was high, his oligoclonal band of eerebrospinal fluid was positive, and abnormal finding in visual evoked potential. Abnormal intramedullary long T2 signals was showed in spinal cord MRI at Tt_7 segment. When dignosed as neuromyelitis optica, the clinical symptom and signs was improved with eorticosteroid and gamma globulin therapy. The patient was in stable condition at present. Conclusions There could be a long term interval between optic neuritis and myelitis. One should pay attention to clinical features and imaging examination of subclinical lesion in spinal cord and brain and conoide the possibility of developing neuromyelitis optiea or multiple sclerosis.
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第3期197-200,共4页 Chinese Journal of Internal Medicine
关键词 视神经脊髓炎 间隔时间 诊断 Neuromyelitis optica Interval Diagnosis
  • 相关文献

参考文献18

  • 1Jacob A,Matiello M,Wingerchuk DM,et al.Neuromyelitis optica:changing concepts.J Neuroimmunol,2007,187:126-138.
  • 2Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica.Neurology,2006,66:1485-1489.
  • 3Wingerchuk DM,Hogancamp WF,O'Brien PC,et al.The clinical course of neuromyelitis optica (Devic's syndrome).Neurology,1999,53:1107-1114.
  • 4Abou Zeid N,Bhatti MT.Acute inflammatory demyelinating optic neuritis:evidence-based visual and neurological considerations.Neurologist,2008,14:207-223.
  • 5Pelidou SH,Giannopoulos S,Tzavidi S,et al.Multiple sclerosis presented as clinically isolated syndrome:the need for early diagnosis and treatment.Ther Clin Risk Manag,2008,4:627-630.
  • 6刘建国,戚晓昆,熊斌,李丽萍,姚生,邱峰.多发性硬化与视神经脊髓炎临床对比研究[J].中华内科杂志,2010,49(2):111-114. 被引量:13
  • 7McDonald WI,Compston A,Edan G,et al.Recommended diagnostic criteria for multiple sclerosis:guidelines from the International Panel on the diagnosis of multiple sclerosis.Ann Neurol,2001,50:121-127.
  • 8Bichuetti DB,Oliveira EM,Souza NA,et al.Neuromyelitis optica in Brazil:a study on clinical and prognostic factors.Mult Scler,2009,15:613-619.
  • 9Miller DH,Weinshenker BG,Filippi M,et al.Differential diagnosis of suspected multiple sclerosis:a consensus approach.Mult Scler,2008,14:1157-1174.
  • 10Nakamura M,Miyazawa I,Fujihara K,et al.Preferential spinal central gray matter involvement in neuromyelitis optica.An MRI study.J Neurol,2008,255:163-170.

二级参考文献21

  • 1戚晓昆.视神经脊髓炎的诊断与治疗[J].中国全科医学,2007,10(12):955-956. 被引量:8
  • 2李劲频,刘竞丽,莫雪安.视神经脊髓炎与多发性硬化关系的对比研究[J].临床荟萃,2005,20(9):512-513. 被引量:4
  • 3汤晓芙.视神经脊髓炎和多发性硬化的关系:54例临床和脑干听觉诱发电位分析[J].中华神经精神科杂志,1989,22(1):23-25. 被引量:12
  • 4魏世辉,周必业.关注神经眼科疾病诊断中的几个热点问题[J].眼科,2006,15(6):366-368. 被引量:9
  • 5Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology, 1999,53 : 1107-1114.
  • 6McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol,2001,50 : 121-127.
  • 7Blanc F, Zephir H, Lebrun C, neuromyelitis optica. Arch Neurol, et al. Cognitive functions in 2008,65:84-88.
  • 8Savettieri G, Messina D, Andreoli V, et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol,2004,251:1208-1214.
  • 9Papais-Alvarenga RM, Carellos SC, Alvarenga MP, et al. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol, 2008,126 : 12-16.
  • 10Bergamaschi R, Tonietti S, Franciotta D, et al. Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult Scler, 2004, 10:2-4.

共引文献37

同被引文献24

  • 1刘占东,王得新,张健,谢琰臣,张春玲,许春玲,薛启蓂.急性横贯性脊髓炎新诊断标准和分类的临床应用[J].临床神经病学杂志,2007,20(3):197-199. 被引量:3
  • 2Warabi Y,Yamazaki M,Shimizu T,et al.Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica[J].Biomed Res Int,2013:847670.
  • 3Goodin DS,Traboulsee A,Knappertz V,et al.Relationship between early clinical characteristics and long term disability outcomes:16 year cohort study (follow-up) of the pivotal interferonβ-1b trial in multiple sclerosis[J].J Neurol Neurosurg Psychiatry,2012,83:282-287.
  • 4Deykin A,Douglas A,Hung S,et al.Interim analysis of 2-year clinical efficacy and safety of peginterferon Beta-1a in patients with relapsing-remitting multiple sclerosis:data from the pivotal phase 3 ADVANCE study[C]//American Academy of Neurology,Annual Meeting,Philadelphia,United States,2014.
  • 5Twyman C,Oyuela P,Palmer J,et al.Thyroid autoimmune adverse events in patients treated with alemtuzumab for relapsingremitting multiple sclerosis:four-year follow-up of the CARE-MS studies[C]//American Academy of Neurology,Annual Meeting,Philadelphia,United States,2014.
  • 6Bienia B,Balabanov R.Immunotherapy of neuromyelitis optica[J].Autoimmune Dis,2013,2013:741490.
  • 7Costanzi C,Matiello M,Lucchinetti CF,et al.Azathioprine:tolerability,efficacy,and predictors of benefit in neuromyelitis optica[J].Neurology,2011,77:659-666.
  • 8Jacob A,Matiello M,Weinshenker BG,et al.Treatment of neuromyelitis optica with mycophenolate mofetil:retrospective analysis of 24 patients[J].Arch Neurol,2009,66:1128-1133.
  • 9Khatri BO,Kramer J,Dukic M,et al.Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica[J].J Clin Apher,2012,27:183-192.
  • 10Bedi GS,Brown AD,Delgado SR,et al.Impact of rituximab on relapse rate and disability in neuromyelitis optica[J].Mult Scler,2011,17:1225-1230.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部